[go: up one dir, main page]

Latest News for: copd

Edit

All Kansas leaders should join Roger Marshall to help COPD patients breathe | Opinion

Kansas City Star 07 Jul 2026
The rest of our state’s congressional delegation should get people the liquid oxygen they need. Opinion ... .
Edit

Nucala's Global Reach Expands with European Approval for COPD Treatment

Nasdaq Globe Newswire 03 Jul 2026
Nucala's growth is driven by a strong commercial base, expansion into COPD treatment after U.S ... COPD treatment after U.S.
Edit

Talmage Cecil Walker

The Laurens County Advertiser 03 Jul 2026
May 8, 1935 – July 3, 2026. Talmage Cecil Walker went home to heaven July 3, 2026, after a long battle with chronic obstructive pulmonary disease (COPD). He passed away peacefully in his home, surrounded by family ... at Westview Memorial Park in Laurens.
Edit

FeNO Predicts Exacerbation Risk in Asthma & COPD (MGC Diagnostics Corporation)

Public Technologies 30 Jun 2026
... nitric oxide (FeNO) testing, along with blood eosinophil counts, could serve as complementary biomarkers to help predict asthma and COPD exacerbation risk.
Edit

Revolutionary injection could cut COPD deaths and prevent life-threatening flare-ups

The Daily Mail 27 Jun 2026
Patients with an incurable lung disease can now access a revolutionary injection that can help prevent life-threatening flare-ups ....
Edit

Chronic Obstructive Pulmonary Disease (COPD) Market Size Expected to Witness Significant Growth by 2036, estimates DelveInsight

GetNews 25 Jun 2026
Emerging COPD therapies including DUPIXENT (dupilumab), NUCALA (mepolizumab), OHTUVAYRE (ensifentrine), Depemokimab (GSK), Itepekimab (Regeneron Pharmaceuticals/Sanofi), Tozorakimab (AstraZeneca), and others are driving market size ... COPD Companies.
Edit

Revolutionary COPD injection given to patients for first time (King's College London)

Public Technologies 23 Jun 2026
For the first time, patients have received a revolutionary new injection for Chronic Obstructive Pulmonary Disease (COPD), developed by King's College London researchers ... Every day in the UK with COPD will tragically die.
Edit

COPD Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by ...

GetNews 23 Jun 2026
In May 2026, Results from a randomized clinical study of EP395, an investigational anti-inflammatory macrolide, demonstrated promising anti-inflammatory effects along with a favorable safety profile in patients with stable COPD.
Edit

COPD attack? No, a pea blocking airway

The Times of India 10 Jun 2026
Comments. +Text SizeSmallMediumLarge. .
Edit

Windward Bio Doses First Patients in Phase 2 SIRIUS COPD Study of Ultra Long-Acting Anti-TSLP ...

Nasdaq Globe Newswire 09 Jun 2026
... monoclonal antibody, in patients with chronic obstructive pulmonary disease (COPD).
Edit

First Patients Dosed in Phase 2 SIRIUS COPD Study of HBM9378/WIN378, a Fully Human Ultra Long-Acting Anti-TSLP Antibody

PR Newswire 09 Jun 2026
COPD is a progressive, irreversible lung disease and the third leading cause of death worldwide ... It is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of HBM9378/WIN378 in patients with moderate-to-severe COPD.
Edit

Daily productive cough causes patient to wonder about COPD

Calhoun Times 08 Jun 2026
DEAR DR ROACH. I decided to practice using an inhalation spirometer, partly because I have a daily productive cough (small amounts three to four times a day). I smoked a pack of filtered cigarettes a day from ages 17-29. I ....
×